Adegboyega Olaseni Olayode, MBBS

Adegboyega Olayode practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Adegboyega Olayode's NPI, 1740569573, was assigned on August 10, 2011. Adegboyega Olayode holds Georgia license 071995.

Adegboyega Olayode's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Adegboyega Olayode's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. The medical group on file is Emory Clinic. Dmand AI also links Adegboyega Olayode to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Adegboyega Olayode practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Adegboyega Olayode's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Adegboyega Olayode's licenses on file in 2 states: Georgia and Nebraska.

CMS data shows 328 Medicare services from Adegboyega Olayode across 4 procedure codes in 2024, for 88 Medicare patients. Medicare paid $28,880 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Adegboyega Olayode in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 65% have high cholesterol. 53% are also on Medicaid. Their average risk score is 3.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Adegboyega Olayode's median patient age at 70, with 57% women.

In 2024, Adegboyega Olayode wrote 171 Medicare Part D claims for 76 patients. 84% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $9,157 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Adegboyega Olayode for performance year 2024, reported through an alternative payment model (APM). Adegboyega Olayode accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Adegboyega Olayode, published from 2022 to 2023. 2022 was the busiest year, with 2. The most frequent topics are Carcinoma, Hepatocellular, Ethnicity and Liver Neoplasms. Adegboyega Olayode has published most often in Clin Gastroenterol Hepatol. Adegboyega Olayode's most frequent co-authors are Hashem Beshir El-Serag, MD, MPH, Vivek Charu, MD and Leila Neshatian Neshatian, MD.

CMS Open Payments shows 1 general payment to Adegboyega Olayode from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $28.